Biomedical subjects

P Boré

Publications and source records attributed to P Boré.

6 recordsLinked to original sources

PubMed1991

Pharmacokinetics of navelbine after oral administration in cancer patients.

The pharmacokinetic behavior of navelbine was investigated in 19 patients presenting with advanced cancers (mainly women with breast cancer). Navelbine was given orally at seven dose levels of up to 200 mg/week. For a given dose, patients received four successive weekly treatments. Five subjects also received two different doses. After drug administration, plasma was collected for 48 or 72 h and monitored for navelbine concentration by radioimmunoassay. Absorption of navelbine was very rapid after oral administration: maximal drug concentrations were reached within the first 1 or 2 h (Tmax, 0.9-1.75 h; cmax, 70.9-832.6 ng/ml), with absorption constants ranging from 0.85 to 2.42 l/h. A comparison of dose-normalised plasma concentration profiles revealed significant time dependence in six evaluable patients (P less than 0.001). Only four subjects who received low doses (less than or equal to 100 mg/week) exhibited time-independent kinetics. All of the five patients who were treated at different doses displayed apparent dose dependence (P less than 0.001). No individual profile was characterised by both time- and dose-independent pharmacokinetics. In all, 18 patients presented biphasic plasma concentration-decay patterns, and only 1 subject exhibited monophasic decay kinetics. The navelbine pharmacokinetic parameters obtained following oral administration were similar to those observed after i.v. bolus injection and were characterised by high oral clearance (0.43-1.45 1 h-1 kg-1), a large apparent volume of distribution (27.4-45.9 1/kg), and a long terminal half-life (24.2-56.5 h). Large intra- and inter-individual variations in pharmacokinetic parameters were observed. Moreover, after a high dose of 200 mg, an enterohepatic cycle and/or a delay in navelbine's absorption at a distal intestinal site as evidenced by a marked plasma level rebound was observed.

Administration, Oral↗

PubMed1991

Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods.

[3H]Navelbine (NVB) was administered orally to two patients. Drug levels in biological fluids were monitored by radioimmunoassay (RIA) and direct radioactivity (RA) determinations. NVB absorption was rapid: maximum plasma concentrations appeared in the first 2 h after oral administrations. Pharmacokinetic parameters estimated from RIA data were in complete accordance with those obtained from i.v. injections. Bioavailability (i.v./po) estimated from RIA and RA data averaged 40.6 and 93.0%, respectively. NVB urine excretion was low. Fecal excretion remained its main elimination route. Moreover, large differences were observed in area under NVB plasma concentration-time curve (AUC) values obtained by the two methods, implying intense drug bio-transformations.

Administration, Oral↗

PubMed1989

Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods.

A study was designed to investigate the fate of navelbine (NVB) and its excretion routes in two cancer patients treated with tritiated NVB (30 mg/m2) by i.v. bolus injection. Plasma and red blood cell concentrations and urine and stool elimination were monitored over long periods of time. NVB plasma and urine concentrations were measured by both radioimmunoassay (RIA) and direct radioactive (RA) determination. Samples were also analyzed by high-performance liquid chromatography to evaluate the importance of NVB metabolism. Whereas the major excretion route for NVB was the stool (from 34% to 58.4% of the total dose given over 21 days), urinary excretion was low (about 21% within the same time period), corresponding mainly to that of unchanged drug. Thus, a good correlation was found between RIA and RA determinations in urine. In contrast, plasma area under the curve (AUC) values obtained after RA and RIA analysis differed markedly (AUC RIA/AUC RA = 0.23-0.31), demonstrating that a significant proportion of the plasma-circulating drug was biotransformed, mainly during the last elimination phase. This could have important pharmacological and toxicologic implications in clinical practice.

Aged↗

PubMed1983

[Trichothiodystrophy: a morphological and biochemical study].

Trichothiodystrophy is a pilar dysplasia which is characterized by the existence of brittle hair with trichoschisis, a typical pattern of transmission of polarized light and decreased levels of sulfur containing amino acids. In this report we show various aspects of the hair dysplasia and of the hair bulbs by light and scanning electron microscopy. Normal levels of cystin in the peripheral blood were associated with decreased levels of this amino acid in the hair shafts. Incorporation of radio-labelled cystine in hair follicles seemed however normal. Our results do not support the generally accepted hypothesis of a defective transport mechanism in the hair follicle. As a similar defect in other tissues (e. g. nervous system, spermatozoids...) is also thought to be responsible for the associated symptoms (e. g. nervous impairment, sterility in males...) we think it is important to lead further research in this field in order to elucidate the metabolic pathways underlying these rare clinical syndromes.

Amino Acids↗

PubMed1982

Capillary gas chromatographic analysis of human skin surface lipids after microsampling on ground-glass platelets.

Small amounts of human skin surface lipids, in the 1-20 micrograms range, sampled on ground-glass platelets are investigated using capillary gas chromatography. A first system allows the separation of the neutral lipids, up to the triglyceride fraction. A second system reveals the distribution of the free fatty acids or of the free + glyceride fatty acids, after a methylation or transesterification step. Examination of samples from nine subjects shows that the unsaturation of the free fatty acids increases during a four-day period of accumulation. Comparison of the free fatty acid fraction and the free + glyceride fatty acid fraction shows that the fraction is more saturated than the latter. It is concluded that the bacterial lipases which cleave the fatty acids from the ester bond favor the liberation of straight-chain saturated fatty acids from sebum triglycerides. This result is confirmed by comparison of the free fatty acid fraction with the glyceride fatty acid fraction separated from bulk samples of skin surface lipids from hair and scalp.

Chromatography, Gas↗

PubMed1979

Studies on the mutagenicity of p-phenylenediamine in Salmonella typhimurium. Presence of PCB's in rat-liver microsomal fraction induced by Aroclor.

The mutagenicity of fresh solutions of p-phenylenediamine (PPD) and Aroclor 1254 was investigated. The histidine-requiring strains of Salmonella typhimurium were used in the absence and presence of uninduced and/or Aroclor-induced rat-liver homogenate. The presence of polychlorinated biphenyls (PCBs) was also examined by chromatographic methods in Aroclor-induced rat-liver homogenate. In the absence of metabolic activation, as well as in the presence of uninduced rat-liver homogenate, PPD was not mutagenic in the strains used. In the presence of Aroclor-induced S9 a twofold increase (or less) was observed in the number of revertant colonies over those of the controls in TA1538 and TA98. There was no increase in the number of revertant colonies over those of the controls when PPD was dissolved in NH4OH solution and the solution mixed with H2O2 before the addition of S9 mix. Aroclor 1254 was not mutagenic in TA1538 or TA98. However, the presence of PCBs in Aroclor-induced rat-liver homogenate (induced S9) was identified by gas-liquid chromatography (GLC), high-performance liquid chromatography (HPLC) and gas--liquid chromatography/mass spectrometry (GC/MS).

Animals↗